[VSsupport]

<img alt="" height="1" width="1" />Ironwood Pharmaceuticals expects $272 million in IPO, proceeds to fund drug ...CanadianBusiness.comIt is aimed at treating irritable bowel syndrome. Data from the late-stage studies is expected in the second half of 2010. The company's partners on the ...<nobr>and more »</nobr>

View the full article